Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Clinical utility of varenicline for smokers with medical and psychiatric comorbidity Ebbert JO; Wyatt KD; Zirakzadeh A; Burke MV; Hays JInt J Chron Obstruct Pulmon Dis 2009[]; 4 (ä): 421-30Chronic obstructive pulmonary disease (COPD) is a costly and deadly disease afflicting an estimated 210 million people and accounting for 5% of all global deaths. Exposure to cigarette smoke is the greatest risk factor for COPD in the developed world. Smoking cessation improves respiratory symptoms and lung function and reduces mortality among patients with COPD. Cigarette smokers with COPD and other co-morbid conditions such as cardiovascular disease and psychiatric illnesses should receive comprehensive tobacco treatment interventions incorporating efficacious pharmacotherapies. Varenicline, an alpha(4)beta(2) nicotinic acetylcholine receptor partial agonist, is the newest and most effective drug currently available to promote smoking cessation. In conjunction with behavioral interventions and clinical monitoring for potential side effects, varenicline offers great hope for reducing smoking-attributable death and disability.|*Mental Disorders/complications[MESH]|Benzazepines/administration & dosage/*therapeutic use[MESH]|Cardiovascular Diseases[MESH]|Drug Labeling[MESH]|Humans[MESH]|Nicotinic Agonists/administration & dosage/*therapeutic use[MESH]|Pulmonary Disease, Chronic Obstructive[MESH]|Quinoxalines/administration & dosage/*therapeutic use[MESH]|Smoking Cessation[MESH]|Smoking/*drug therapy[MESH]|Tobacco Use Disorder/complications/drug therapy[MESH]|Treatment Outcome[MESH]|Varenicline[MESH] |